Endoscopic Evaluation of the Paediatric Airway After Prior Prolonged (>24 h) Tracheal Intubation
NCT ID: NCT02350933
Last Updated: 2018-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1000 participants
INTERVENTIONAL
2011-09-30
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Airway Complications in Pediatric Patients With Tracheostomies: To What Extent Can Symptoms Identified by Caregivers or Pediatricians Serve as Predictors for Airway Complications Confirmed Through Surveillance Endoscopy?"
NCT07121517
Oxygen Insuflation and ArterialDesaturation During Tracheal Intubation in Children
NCT01664234
Success of Pediatric Anesthesiologists in Learning to Use Videolaryngoscopes
NCT01215422
Pediatric Videolaryngoscopic Intubation and Difficult Airway Classification
NCT04844723
Complications Related to the Anaesthesia During Airway Endoscopy in Children with Tracheostomy.
NCT06906263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After induction of anaesthesia and obtaining venous access, neuromuscular blocking agents are administered and facemask pre-oxygenation occurs for 2 minutes. Direct laryngoscopy is then performed in the preoxygenated, paralysed and conventionally monitored patient to obtain a direct vision. Then a rigid endoscope with endoscopy camera is carefully guided through the larynx down to the carina and drawn back under monitor vision with electronic recording.
An International Study Board Committee (assessor board) will assess the endoscopic records in a blinded manner using a systematic grading system.
Beside tracheal tube type, factors such as intubator, sedation management, age, length of intubation, nasal or oral intubation and time point of endoscopy will affect presence, absence or incidence of potential airway injuries caused by prolonged tracheal intubation. Thus it is difficult to perform a power calculation to figure out number of patients to demonstrate or exclude a statistically significant difference between tube types. Using the incidence of subglottic stenosis, as the worst case scenario outcome after longterm intubation, an incidence of less than 2 % seems to be reasonable in uncuffed tracheal tubes.So the primary hypothesis to be tested is equivalence in major complication rates defined as subglottic stenosis comparing cuffed versus uncuffed tracheal tubes.
Specifically, the primary hypothesis relates to the main outcome criteria of this study, which is subglottic stenosis after longterm intubation. The null-hypothesis Ho is defined as no difference in the incidence rates of subglottic stenosis between cuffed and uncuffed groups. The null-hypothesis (Ho: μ-Diff = 0) will be compared with the alternative hypothesis (H1: μ-Diff \<\> 0). The study is designed to detect a clinically unacceptable deterioration of 4% above the baseline airway-injury rate of 2% when using uncuffed tubes with a power of 80% and a type I error probability of less than 5%. Sample sizes of 376 from the cuffed group and 376 from the uncuffed group achieve 80% power at a 5% significance level using a one-sided equivalence test of proportions when the proportion in the standard group (uncuffed TT) is 0.02 and the proportion in the experimental group (cuffed TT) being tested for equivalence is 0.02 and the maximum allowable increase between these proportions that still results in equivalence (the range of equivalence) is 0.04. In total 1000 patients with prior long-term intubation (\> 24 hours) using a cuffed (500) or an uncuffed (500) tracheal tube will be recruited / included from different study centres.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
0° rigid endoscope
Endoscopy of the trachea is performed using a 0° rigid endoscope
Endoscopy
A rigid endoscopy of the larynx and the trachea until the carina is performed using a rigid 0° endoscope.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopy
A rigid endoscopy of the larynx and the trachea until the carina is performed using a rigid 0° endoscope.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Written parental consent
* American Society of Anesthesiologists (ASA) physical status \< IV
* No parental written consent
* Known airway anomalies associated with syndromes
* Known or suspected difficult intubation
* Emergency surgery or intervention
* Full stomach and/or at risk for regurgitation
* ASA physical status IV and higher
* Patients with current or prior tracheostomy
* Known, suspected or potential cervical spine pathology (e.g. Down's Syndrome)
* Insufficient clinical details from previous prolonged intubation
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Great Ormond Street Hospital for Children NHS Foundation Trust
OTHER
Asklepios-Klinik Sankt Augustin
OTHER
Kinderkrankenhaus Amsterdamer Straße
UNKNOWN
Erasmus Medical Center
OTHER
University Children's Hospital, Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Markus Weiss, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Children's Hospital, Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kinderkrankenhaus Amsterdamer Straße
Cologne, North Rhine-Westphalia, Germany
Asklepios Kinderklinik Sankt Augustin
Sankt Augustin, North Rhine-Westphalia, Germany
Erasmus Medical Center, Sophia Children's Hospital
Rotterdam, , Netherlands
University Children's Hospital
Zurich, , Switzerland
Great Ormond Street Hospital for Children NHS Foundation Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Endostudy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.